I 1111111111111111 1111111111 111111111111111 11111 1111111111111111 IIII IIII IIII
`US010478634B2
`
`c12) United States Patent
`Schwarz et al.
`
`US 10,478,634 B2
`(IO) Patent No.:
`(45) Date of Patent:
`Nov. 19, 2019
`
`(54) AESTHETIC METHOD OF BIOLOGICAL
`STRUCTURE TREATMENT BY MAGNETIC
`FIELD
`
`(71) Applicant: BTL Medical Technologies S.R.O.,
`Prague (CZ)
`
`(72)
`
`Inventors: Tomas Schwarz, Prague (CZ); Ondra
`Prouza, Ricany u Prahy (CZ)
`
`(73) Assignee: BTL Medical Technologies S.R.O.,
`Prague (CZ)
`
`( * ) Notice:
`
`Subject to any disclaimer, the term ofthis
`patent is extended or adjusted under 35
`U.S.C. 154(b) by O days.
`
`(21) Appl. No.: 16/034,793
`
`(22) Filed:
`
`Jul. 13, 2018
`
`(65)
`
`Prior Publication Data
`
`US 2019/0192875 Al
`
`Jun. 27, 2019
`
`Related U.S. Application Data
`
`(63) Continuation-in-part of application No. 15/954,783,
`filed on Apr. 17, 2018, which is a continuation-in-part
`(Continued)
`
`(51)
`
`Int. Cl.
`A61N 2104
`A61N 2102
`
`(2006.01)
`(2006.01)
`(Continued)
`
`(2013.01); A61B 2018/00672 (2013.01); A61B
`2018/00678 (2013.01); A61B 2018/00708
`(2013.01);
`
`(Continued)
`(58) Field of Classification Search
`CPC ... A61N 5/06; A61N 2/00; A61N 2/02; A61N
`2/002; A61N 2/004; A61N 2/006; A61N
`2/008; A61K 41/0004
`USPC ................................................... 600/9, 3, 14
`See application file for complete search history.
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`3,658,051 A
`3,915,151 A
`
`4/1972 MacLean et al.
`10/1975 Kraus
`(Continued)
`
`FOREIGN PATENT DOCUMENTS
`
`CN
`EP
`
`7/2011
`201906360 U
`1/1987
`0209246 Al
`(Continued)
`
`OTHER PUBLICATIONS
`
`Weight to volume copper, 2 pages printed from internet Sep. 25,
`2018.*
`
`(Continued)
`
`Primary Examiner - Samuel G Gilbert
`(74) Attorney, Agent, or Firm - Sterne, Kessler,
`Goldstein & Fox P.L.L.C.
`
`(52) U.S. Cl.
`CPC .............. A61N 2102 (2013.01); A61B 181203
`(2013.01); A61N 21006 (2013.01); A61B
`18/201 (2013.01); A61B 2017/00482
`(2013.01); A61B 2018/00452 (2013.01); A61B
`2018/00464 (2013.01); A61B 2018/00559
`(2013.01); A61B 2018/00577 (2013.01); A61B
`2018/00589 (2013.01); A61B 2018/00642
`
`(57)
`
`ABSTRACT
`Methods for treating a patient using time varying magnetic
`field are described. The treatment methods combine various
`approaches for aesthetic treatment. The methods are focused
`on enhancing a visual appearance of the patient.
`
`30 Claims, 21 Drawing Sheets
`
`Allergan EX1007
`Page 1
`
`

`

`US 10,478,634 B2
`Page 2
`
`Related U.S. Application Data
`
`(56)
`
`References Cited
`
`of application No. 15/862,410, filed on Jan. 4, 2018,
`and a continuation-in-part of application No. 15/677,
`371, filed on Aug. 15, 2017, now Pat. No. 9,974,519,
`and a continuation-in-part of application No. 15/601,
`719, filed on May 22, 2017, said application No.
`15/862,410 is a continuation-in-part of application
`No. 15/473,390, filed on Mar. 29, 2017, now aban-
`doned, said application No. 15/677,371 is a continu-
`ation-in-part of application No. 15/446,951, filed on
`Mar. 1, 2017, now Pat. No. 9,937,358, and a continu-
`ation-in-part of application No. 15/404,384, filed on
`Jan. 12, 2017, said application No. 15/446,951 is a
`continuation-in-part of application No. 15/396,073,
`filed on Dec. 30, 2016, now abandoned, which is a
`continuation-in-part of application No. 15/178,455,
`filed on Jun. 9, 2016, now abandoned, which is a
`continuation-in-part of application No. 15/151,012,
`filed on May 10, 2016, now Pat. No. 10,124,187,
`which is a continuation-in-part of application No.
`15/099,274, filed on Apr. 14, 2016, now abandoned,
`which is a continuation-in-part of application No.
`15/073,318, filed on Mar. 17, 2016, now Pat. No.
`9,919,161, which is a continuation-in-part of appli-
`cation No. 14/951,093, filed on Nov. 24, 2015, now
`abandoned, which is a continuation-in-part of appli-
`cation No. 14/926,365, filed on Oct. 29, 2015, now
`abandoned, which is a continuation-in-part of appli-
`cation No. 14/789,658, filed on Jul. 1, 2015, now Pat.
`No. 9,636,519, and a continuation-in-part of applica-
`tion No. 14/789,156, filed on Jul. 1, 2015, said
`application No. 15/862,410 is a continuation-in-part
`of application No. 15/860,443, filed on Jan. 2, 2018.
`
`(60) Provisional application No. 62/440,912, filed on Dec.
`30, 2016, provisional application No. 62/440,936,
`filed on Dec. 30, 2016, provisional application No.
`62/440,940, filed on Dec. 30, 2016, provisional
`application No. 62/440,905, filed on Dec. 30, 2016,
`provisional application No. 62/440,922, filed on Dec.
`30, 2016, provisional application No. 62/357,679,
`filed on Jul. 1, 2016, provisional application No.
`62/441,805, filed on Jan. 3, 2017.
`
`(51)
`
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`
`Int. Cl.
`A61B 18120
`A61N 2100
`H0lF 7/06
`A61B 18/00
`A61N 5/06
`A61N 7/00
`A61B 17/00
`A61N 5/067
`(52) U.S. Cl.
`CPC ............... A61B 2018/00791 (2013.01); A61B
`2018/00809 (2013.01); A61B 2018/00994
`(2013.01); A61B 2018/20351 (2017.05); A61N
`2/002 (2013.01); A61N 5/0616 (2013.01);
`A61N 5/0625 (2013.01); A61N 7/00 (2013.01);
`A61N 2005/067 (2013.01); A61N 2005/0628
`(2013.01); A61N 2005/0644 (2013.01); A61N
`2005/0649 (2013.01); A61N 2005/0659
`(2013.01); A61N 2005/0661 (2013.01); H0lF
`7/064 (2013.01)
`
`U.S. PATENT DOCUMENTS
`
`12/1980 Whalley
`4,237,898 A
`2/1982 Ryaby
`4,315,503 A
`6/1984 Fellus
`4,454,883 A
`6/1984 Pescatore
`4,456,001 A
`5/1987 Costa
`4,665,898 A
`6/1987 Pauli et al.
`4,674,505 A
`2/1991 McLeod
`4,993,413 A
`2/1992 Frey
`5,085,626 A
`3/1995 Erickson
`5,401,233 A
`2/1998 Jalinous
`5,718,662 A
`6/1998 Polson
`5,766,124 A
`9/1998 Espinoza
`5,807,232 A
`6/1999 Azure
`5,908,444 A
`5,984,854 A * 11/1999 Ishikawa .................. A61N 2/02
`600/9
`
`5/2000 Salansky
`6,063,108 A
`7/2000 Davey et al.
`6,086,525 A
`9/2000 Abrams
`6,117,066 A
`1/2001 Ishikawa
`6,179,769 Bl
`1/2001 Mould
`6,179,770 Bl
`4/2001 Lin
`6,213,933 Bl
`5/2001
`Ishikawa
`6,223,750 Bl
`6/2002 Fischell
`6,402,678 Bl
`7/2002 Tepper
`6,418,345 Bl
`3/2003 Ishikawa
`6,527,694 Bl
`5/2003 Ishikawa
`6,569,078 B2
`9/2005 Ardizzone
`6,939,287 Bl
`4/2006 Smith
`7,030,764 B2
`4/2009 Simon
`7,520,849 Bl
`10/2009 Riehl
`7,601,115 B2
`10/2009 Farone
`7,608,035 B2
`6/2010 Pilla
`7,740,574 B2
`6/2010 Epstein
`7,744,523 B2
`5/2011 Peterchev
`7,946,973 B2
`8/2011 Aho
`7,998,053 B2
`1/2012 Juliana
`8,088,058 B2
`3/2015 Ron et al.
`8,979,727 B2
`4/2015 Burnett
`9,002,477 B2
`3/2017 Ladman et al.
`9,586,057 B2
`5/2017 Ladman et al.
`9,636,519 B2
`3/2018 Schwarz et al.
`9,919,161 B2
`4/2018 Schwarz et al.
`9,937,358 B2
`11/2018 Schwarz et al.
`10,124,187 B2
`4/2019 Schwarz et al.
`10,245,439 Bl
`10/2001 Ishikawa
`2001/0031906 Al
`8/2003 Burnett
`2003/0158585 Al
`7/2006 Rohwedder
`2006/0152301 Al
`8/2006 Mo
`2006/0187607 Al
`12/2006 Zangen et al.
`2006/0287 566 Al
`10/2008 Marchitto
`2008/0249350 Al
`2008/0262287 Al
`10/2008 Dussau
`12/2008 Burnett et al.
`2008/0306325 Al
`12/2008 Epstein
`2008/0306326 Al
`1/2009 Simenhaus
`2009/0005631 Al
`2009/0018384 Al
`1/2009 Boyden et al.
`4/2009 Sims et al.
`2009/0108969 Al
`2/2010 England
`2010/0036368 Al
`4/2010 Allison
`2010/0081971 Al
`4/2010 Peterchev
`2010/0087699 Al
`5/2010 Mathes
`2010/0121131 Al
`6/2010 Roth et al.
`2010/0152522 Al
`6/2010 Burnett et al.
`2010/0160712 Al
`7/2010 Glassman
`2010/0179372 Al
`9/2010 Burnett et al.
`2010/0222629 Al
`2010/0309689 Al * 12/2010 Coulson ............ H02M 3/33507
`363/16
`
`2010/0331603 Al
`2011/0021863 Al
`2011/0077451 Al
`2011/0130618 Al
`2011/0263925 Al
`2012/0053449 Al
`2012/0302821 Al
`2012/0310033 Al
`2013/0030239 Al
`
`12/2010 Szecsi
`1/2011 Burnett
`3/2011 Marchitto
`6/2011 Ron et al.
`10/2011 Bratton
`3/2012 Moses
`11/2012 Burnett
`12/2012 Muntermann
`1/2013 Weyh
`
`Allergan EX1007
`Page 2
`
`

`

`US 10,478,634 B2
`Page 3
`
`A61N 2/02
`600/14
`
`A61N 2/02
`600/14
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`2013/0053620 Al
`2013/0123568 Al
`2013/0123764 Al
`2013/0123765 Al
`2013/0137918 Al*
`
`2/2013 Susedik et al.
`5/2013 Hamilton
`5/2013 Zarsky et al.
`5/2013 Zarsky et al.
`5/2013 Phillips
`
`2013/0150653 Al
`2013/0158634 Al
`2013/0238061 Al
`2013/0317281 Al
`2013/0331637 Al
`2014/0046423 Al
`2014/0148870 Al
`2014/0330067 Al
`2014/0371515 Al
`2015/0025299 Al
`2015/0123661 Al
`2015/0133717 Al
`2015/0157873 Al*
`
`6/2013 Borsody
`6/2013 Ron Edoute
`9/2013 Ron Edoute
`11/2013 Schneider
`12/2013 Greff
`2/2014 Rajguru
`5/2014 Burnett
`11/2014 Jordan
`12/2014 John
`1/2015 Ron Edoute
`5/2015 Yui
`5/2015 Ghiron
`6/2015 Sokolowski
`
`2015/0216719 Al
`2015/0328475 Al
`2015/0367141 Al
`2016/0030763 Al
`2016/0051827 Al
`2016/0250494 Al
`2017/0001024 Al
`2017/0001025 Al
`2017/0001029 Al
`2017/0001030 Al
`2017 /0072212 Al
`2017/0106201 Al
`2017/0120067 Al
`2018/0001106 Al
`2018/0125416 Al
`2018/0236254 Al
`
`8/2015 Debenedictis
`11/2015 Kim
`12/2015 Goetz
`2/2016 Midorikawa
`2/2016 Ron Edoute
`9/2016 Sakaki
`1/2017 Prouza
`1/2017 Schwarz et al.
`1/2017 Pribula et al.
`1/2017 Pribula et al.
`3/2017 Ladman et al.
`4/2017 Schwarz et al.
`5/2017 Prouza
`1/2018 Schwarz
`5/2018 Schwarz et al.
`8/2018 Schwarz et al.
`
`FOREIGN PATENT DOCUMENTS
`
`EP
`JP
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`WO
`
`2676700 A2
`2017 /518857 A
`2002025675 Al
`2003090863 Al
`2004087255 Al
`20081090581
`2010007614 A3
`2010135425 Al
`2015012672 Al
`2015/179571 Al
`
`12/2013
`7/2017
`3/2002
`11/2003
`10/2004
`9/2008
`1/2010
`11/2010
`1/2015
`11/2015
`
`OTHER PUBLICATIONS
`
`Weight to volume aluminum, 2 pages. printed from internet Sep. 25,
`2018.*
`Lin, et al., "Functional Magnetic Stimulation: A New Modality for
`Enhancing Systemic Fibrinolysis," Arch Phys Med Rehabil vol. 80,
`May 1999, pp. 545-550.
`Abulhasan, J.F., et al., "Peripheral Electrical and Magnetic Stimu(cid:173)
`lation to Augment Resistance Training," Journal of Functional
`Morphology and Kinesiology, 1(3):328-342, (Sep. 2016).
`Bachasson, D., et al., "Quadriceps Function Assessment Using an
`Incremental Test and Magnetic Neurostimulation: a Reliability
`Study," Journal of Electromyography and Kinesiology, 23(3):649-
`658, Elsevier, England, (Jun. 2013).
`Barker, A.T, "An Introduction to the Basic Principles of Magnetic
`Nerve Stimulation," Journal of Clinical Neurophysiology, 8(1):26-
`37, Lippincott Williams & Wilkins, United States, (Jan. 1991).
`Behrens, M., et al., "Repetitive Peripheral Magnetic Stimulation (15
`Hz RPMS) of the Human Soleus Muscle did not Affect Spinal
`Excitability," Journal of Sports Science and Medicine, 10(1):39-44,
`Dept. of Sports Medicine, Medical Faculty of Uludag University,
`Turkey (Mar. 2011).
`
`Beilin, G., et al., "Electromagnetic Fields Applied to the Reduction
`of Abdominal Obesity," Journal of Cosmetic & Laser Therapy,
`14(1):24-42, Informa Healthcare, England, (Feb. 2012).
`Bustamante, V., et al., "Muscle Training With Repetitive Magnetic
`Stimulation of the Quadriceps in Severe COPD Patients," Respira(cid:173)
`tory Medicine, 104(2):237-245, Elsevier, England, (Feb. 2010).
`Bustamante, V., et al., "Redox Balance Following Magnetic Stimu(cid:173)
`lation Training in the Quadriceps of Patients With Severe COPD,"
`Free Radical Research, 42(11-12):939-948, Informa Healthcare,
`England, (Nov. 2008).
`Caress, J.B., et al., "A Novel Method of Inducing Muscle Cramps
`Using Repetitive Magnetic Stimulation," Muscle Nerve, 23( 1 ): 126-
`128, John Wiley & Sons, United States, (Jan. 2000).
`CR Technology, Salus-Talent, Technical File of Electro-magnetic
`Stimulator, Document No. TF-005, 2008, 241 pages.
`CR Technology, Technology for Health and Business for Human
`Being, investor relations, 2008, 21 pages.
`Dokumentace, P., Magneticky Stimulator DuoMAG, Technicky
`popis a navod k pouziti, 2012, 24 Pages.
`Effective PEMF Magnetic Fat Reduction Slimming Body Beauty
`Salon Machine (PEMF Star), Wolfbeauty 1980, PEMF STAR,
`China, Retrieved from the Internet: (URL: https://www.ec2l.com/
`product-details/Effective-PEMF-Magnetic-Fat-Reduction--8928746.
`html), 2019, 5 pages.
`Goetz, S.M., et al., "Coil Design for Neuromuscular Magnetic
`Stimulation Based on a Detailed 3-D Thigh Model," IEEE Trans(cid:173)
`actions on Magnetics, 50(6): 10, IEEE, (Jun. 2014).
`Gorodnichev, R.M., "Magnetic Stimulation of Muscles as New
`Method to Enhance Their Strength, " Velikie Luki State Academy
`of Physical Culture and Sport, Velikie Luki, 2016, 5 pages.
`Hanmegard, C.H., et al., "Quadriceps Strength Assessed by Mag(cid:173)
`netic Stimulation of the Femoral Nerve in Normal Subjects,"
`Clinical Physiology and Functional Imaging, 24(5):276-280, Blackwell,
`England, (Sep. 2004).
`Han, T.R., et al., "Magnetic Stimulation of the Quadriceps Femoris
`Muscle: Comparison of Pain With Electrical Stimulation," Ameri(cid:173)
`can Journal of Physical Medicine & Rehabilitation, 85(7):593- 599,
`Lippincott Williams & Wilkins, United States, (Jul. 2006).
`Increasing Physiotherapy Presence in Cosmetology, SPA Inspira(cid:173)
`tions, Jan. 2012, pp. 34-35.
`Iskra Medical, Magneto System, 2012, 2 pages.
`Lampropoulou, S.I., et al., "Magnetic Versus Electrical Stimulation
`in the Interpolation Twitch Technique of Elbow Flexors," Journal of
`Sports Science and Medicine, 11(4):709-718, Dept. of Sports Medi(cid:173)
`cine, Medical Faculty of Uludag University, Turkey (Dec. 2012).
`Lin, V.W., et al., "Functional Magnetic Stimulation for Restoring
`Cough in Patients With Tetraplegia," Archives of Physical Medicine
`and Rehabilitation, 79(5):517-522, W.B. Saunders, United States,
`(May 1998).
`Lin, V.W., et al., "Functional Magnetic Stimulation of Expiratory
`Muscles: a Noninvasive and New Method for Restoring Cough,"
`Journal of Applied Physiology (1985), 84(4):1144-1150, American
`Physiological Society, United States, (Apr. 1998).
`Madariaga, V.B., et al., "[Magnetic Stimulation of the Quadriceps:
`Analysis of 2 Stimulators Used for Diagnostic and Therapeutic
`Applications]," Archivos De Bronconeumologia, 43(7):411- 417,
`Elsevier Espana, Spain, (Jul. 2007).
`Mag Venture, Magnetic Stimulation, Accessories Catalogue, Acces(cid:173)
`sories Catalogue, 2011, 54 pages.
`MagVenture, MagPro® by MagVenture®, Versatility in Magnetic
`Stimulation, World Leading Transcranial Magnetic Stimulation
`Systems, 2011, 6 Pages.
`Neuro Star, TMS Therapy, Bringing Hope to Patients with Depres(cid:173)
`sion, 2013, 6 Pages.
`Neurosoft, Ivanovo, Since 1992, Magnetic Stimulator, NEURO(cid:173)
`MS, Technical Manual, Neurosoft Ltd, Ivanovo, Russia, 2006, 67
`Pages.
`Nexstim NBS System, Navigated Brain Stimulation, Noninvasive,
`direct cortical mapping, 2012, 5 Pages.
`Obsluze, N. K., Uzivatelsky manual, Pristroj pro vysokoindukcni
`magnetickou stimulaci, typove oznaceni, Saluter Moti, 2016, 42
`Pages.
`
`Allergan EX1007
`Page 3
`
`

`

`US 10,478,634 B2
`Page 4
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Operating Manual: Magstim D702 Coil, MOP06-EN, Revision 01,
`The Magstim Company Limited, Feb. 2012, 14 Pages.
`Operating Manual: Magstim Magstim 2002, MOP0l-EN, Revision
`01, The Magstim Company Limited, Sep. 2011, 25 Pages.
`Operating Manual: Magstim, Magstim Alpha Coil Range, MOPll(cid:173)
`EN, Revision 01, Oct. 2012, 18 Pages.
`Operating Manual: Magstim, Magstim Bistim2, MOP02-EN, Revi(cid:173)
`sion, The Magstim Company Limited, 01, Sep. 2011, 27 Pages.
`Operating Manual, Magstim, Model 200, PIN. 3001-01, Double
`70mm, Remote Coil, PIN. 3190-00, The Magstim Company Lim(cid:173)
`ited, 2006, 32 pages.
`Operating Manual: Magstim R, 2nd, Generation Coil Family, 3100-
`23-02, Magstim Coils, The Magstim Company Limited, Nov. 2002,
`14 Pages.
`Operating Manual, MAGSTIM R Air-Cooled Double 70mm Coil
`System, 1600-23-04, The Magstim Company Limited, 1999, 18
`Pages.
`Operating Manual: MAGSTIM R, BISTIM System, PIN. 3234-23-
`01, The Magstim Company Limited, Nov. 2004, 30 Pages.
`Operating Manual: Magstim R, Coils & Accessories, 1623-23-07,
`Magstim Coils & Accessories, May 2010, 24 Pages.
`Operating Manual: Magstim, RAPID 2, PIN. 3576-23-09, The Magstim
`Company Ltd, Nov. 2009, 61 Pages.
`Operator'S Manual: BTL EMSCULPT, BTL Industries Ltd, United
`Kingdom, 2018, 35 pages.
`Operator'S Manual: BTL, HPM-6000U, BTL Industries Ltd, United
`Kingdom, Dec. 2016, 36 pages.
`Papimi, For Scientific Research, Pap Ion Magnetic Inductor, Pre(cid:173)
`sentation, Magnetotherapeutic Device, Nov. 2009, 61 Pages.
`Podebradsky.K., et al., Clinical study of high-inductive electromag(cid:173)
`netic stimulator Salus talent, 2010, 8 pages.
`Polkey M.I., et al., "Functional Magnetic Stimulation of the Abdomi(cid:173)
`nal Muscles in Humans, " American Journal of Respiratory and
`Critical Care Medicine, 160(2):513-522, American Thoracic Soci(cid:173)
`ety, United States (Aug. 1999).
`Polkey, M.I., et al., "Quadriceps Strength and Fatigue Assessed by
`Magnetic Stimulation of the Femoral Nerve in Man," Muscle
`Nerve, 19(5):549-555, John Wiley & Sons, United States, (May
`1996).
`Quick Start Manuals, MAGSTIM Super Rapid Plus Quick Start,
`Aalto TMS Laboratory, Aalto School of Science, 2013, 7 Pages.
`
`Salus Talent-A, Remed, User Guide, High Intensity Electro Mag(cid:173)
`netic Field Therapy, 2017, 37 pages.
`Polk, C., "Therapeutic Applications of Low-Frequency Sinusoidal
`and Pulsed Electric and Magnetic Fields," The Biomedical Engi(cid:173)
`neering Handbook, vol. 1, 2000, Second edition, CRC Press LLC,
`pp. 1625-1636.
`Szecsi, J., et al., "A Comparison of Functional Electrical and
`Magnetic Stimulation for Propelled Cycling of Paretic Patients,"
`Archives of Physical Medicine and Rehabilitation, 90(4):564-570,
`W.B. Saunders, United States, (Apr. 2009).
`Szecsi, J., et al., "Force-pain Relationship in Functional Magnetic
`and Electrical Stimulation of Subjects With Paresis and Preserved
`Sensation," Clinical Neurophysiology, 121(9): 1589-1597, Elsevier,
`Netherlands, (Sep. 2010).
`Taylor, J.L, "Magnetic Muscle Stimulation Produces Fatigue With(cid:173)
`out Effort," Journal of Applied Physiology (1985), 103(3):733-734,
`American Physiological Society, United States, (Sep. 2007).
`Tesla Stym, Iskra Medical, Tone the inner muscle with FMS
`Functional Magnetic Stimulation, 2013, 4 pages.
`User Guide: Mag Venture, Magpro family, MagPro R30, MagPro
`R30 with MagOption, MagPro Xl00, MagPro Xl00 with MagOp(cid:173)
`tion, MagPro software v.5.0, US-edition, MagPro family User
`Guide, 2010, 52 Pages.
`User Guide, Salus Talent Pro, REMED, High Intensity Electro
`magnetic Field Therapy-2 Channel, 2017, Version M-1.0.0, 45
`pages.
`User Guide, Salus Talent, REMED, High Intensity Electro magnetic
`Field Therapy, Version. M-1.0.0, 2017, 40 pages.
`User'S Manual: BTL-6000, Super Inductive System Elite, BBTL
`Industries Ltd, United Kingdom, Sep. 2016, 36 pages.
`User Manual: Electro-magnetic Stimulator, Salus-Talent, Version
`1.00, Rehabilitation Medical Company, 2013, 34 Pages.
`User Manual: Regenetron PRO, System Information, Regenetron
`PRO User Manual, Nov. 2014, 7 Pages.
`Verges S., et al., "Comparison of Electrical and Magnetic Stimula(cid:173)
`tions to Assess Quadriceps Muscle Function," Journal of Applied
`Physiology (1985), 106(2):701-710, American Physiological Soci(cid:173)
`ety, United States, (Feb. 2009).
`Wasilewski, M.L., Academy of Aesthetic and Anti-Aging Medicine,
`Application of magnetic fields with deep stimulation in the fight
`against local obesity of lower limbs, BTL, 2012, 4 pages.
`Course in Physical Therapy, Presentation, Jan. 4, 2013.
`
`* cited by examiner
`
`Allergan EX1007
`Page 4
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 1 of 21
`
`US 10,478,634 B2
`
`Multiple insulated
`,.,., . ...-wires
`
`Figure 1
`
`6
`
`*····
`
`*··--
`
`*··--
`
`◄----
`
`"'"" ;"'"" "·
`·;~~\~l~~ ·~•··----- 4
`
`..............................................
`~----
`•----
`•····
`*··--
`
`◄----
`
`◄----
`
`3
`
`1
`
`Figure 2
`
`49
`
`10
`
`Figure 3a
`
`8
`
`7/
`
`Allergan EX1007
`Page 5
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 2 of 21
`
`US 10,478,634 B2
`
`8
`
`49
`
`Figure 3b
`
`51
`
`Figure 3c
`
`9
`
`Allergan EX1007
`Page 6
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 3 of 21
`
`US 10,478,634 B2
`
`12
`
`11
`
`14
`
`Figure 4a
`
`Allergan EX1007
`Page 7
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 4 of 21
`
`US 10,478,634 B2
`
`19
`
`12
`
`17
`
`Figure 4b
`
`Figure 4c
`
`Allergan EX1007
`Page 8
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 5 of 21
`
`US 10,478,634 B2
`
`. . . - - - - - - - cu - - -
`
`115
`
`+
`
`PS
`
`26J
`
`25
`
`24
`
`L
`
`Figure 5a
`
`...----1 cu
`
`+
`
`PS
`
`31
`
`SW ~30
`
`28
`
`L
`
`29
`
`Figure Sb
`
`Allergan EX1007
`Page 9
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 6 of 21
`
`US 10,478,634 B2
`
`r
`
`R
`
`• •
`
`. I
`
`Figure 6
`
`/\
`\".
`
`1000
`
`{';
`.. , .. +:~·-• '"
`
`500
`
`·1
`i
`
`0
`
`-500
`
`-1000
`
`-1500 .__ _ __ _ .,__ _ ___ ......_ ____ _.._ ____ __,_ ____ ___.
`2000
`500
`1000
`1500
`
`time [µs]
`
`Figure 7
`
`Allergan EX1007
`Page 10
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 7 of 21
`
`US 10,478,634 B2
`
`T1
`
`T2
`
`time
`
`Figure 8
`
`32
`
`fat
`
`~35
`
`33
`
`34
`
`36
`
`Figure 9
`
`Allergan EX1007
`Page 11
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 8 of 21
`
`US 10,478,634 B2
`
`39
`38
`
`40
`
`Figure 10a
`
`41
`
`42
`
`Figure 10b
`
`Allergan EX1007
`Page 12
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 9 of 21
`
`US 10,478,634 B2
`
`45
`
`44
`
`46
`
`Figure 11a
`
`47
`
`48
`
`Figure 11b
`
`Allergan EX1007
`Page 13
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 10 of 21
`
`US 10,478,634 B2
`
`56
`55
`54
`................................................................................. .
`
`---------- ···~
`
`~....
`
`52 \
`
`53
`
`58
`
`C2
`--4------11---..-.
`.
`57 / · · .............................................................................. ·······/
`
`59
`
`60
`
`61
`
`Figure 12
`
`Figure 13
`
`Allergan EX1007
`Page 14
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 11 of 21
`
`US 10,478,634 B2
`
`T W l TC H
`
`INCOMPLETE
`TETANUS
`
`COMPLETE
`TETANUS
`
`\. \ s
`
`Figure 14
`
`Figure 15
`
`Allergan EX1007
`Page 15
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 12 of 21
`
`US 10,478,634 B2
`
`Figure 16
`
`63
`
`62
`
`64
`
`•••••••••• /
`
`•••••••••••• !
`• ,.
`• .. • ,.
`
`·----- :
`
`: ------·
`!································:
`" ..
`• • ..
`• ..
`" " " ..
`• " ..,_ ttlt: . . .
`
`Figure 17
`
`... /66
`... ---.. ;
`
`•
`" • ..
`" " •
`
`: ................. !
`: --------:
`. ..
`" " " • .
`:... ..... \
`--.---...
`" "
`
`70
`
`71
`
`Allergan EX1007
`Page 16
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 13 of 21
`
`US 10,478,634 B2
`
`:············f·~~---····
`..
`,. .. .. .. ,. ..
`
`73
`
`74
`
`• .. .. ..
`
`.. ,. .. .. .. ,. .. « .. ,. .. .. .. ,. .. .. « .. .. .. .. .. ..
`
`" ..
`" ..
`" .. .. ,. ..
`" ..
`" ..
`" ..
`" ~•x••••••••••••••••••••••••••••=
`
`77
`
`Figure 18a
`
`.. .. .. .. .. • .. • ..
`
`• ..
`
`" .. ,. ..
`" ..
`
`81
`
`..
`" • ..
`• " • .. ..
`• " • ..
`• ••••••••••••••••
`82
`
`• .. • .. • • ..
`• .. • ..
`.................
`•
`
`Figure 18b
`
`.. }76
`• . • . • . • .
`.,. _____ _
`.
`.
`...............
`-
`-
`.
`..
`.
`•
`.
`•
`•
`•
`
`•
`•
`•
`•
`• •
`•
`•
`•
`•
`•
`
`...\
`
`~
`
`78
`
`79
`
`,.
`
`r·······j84
`.. .. .. • ..
`,. .. .. • ,.
`...
`• .. •
`.
`.
`a..-----:
`..
`,.
`~ tel tr ·••tr ......
`, ....... *••-:
`...----.. : ..
`..
`..
`• ..
`• " •
`• ,. ..
`• ..
`• ,.
`····~
`
`85
`
`86
`
`Allergan EX1007
`Page 17
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 14 of 21
`
`US 10,478,634 B2
`
`89
`
`90
`
`88
`
`95
`
`:••···········f ~~ .....
`
`.........
`..
`"
`•
`" ,.
`..
`•
`"
`"
`•
`"
`,.
`• ..
`"
`"
`•
`"
`,.
`.,
`..
`•
`..
`"
`..
`"
`•
`.,
`•
`..
`"
`..
`"
`"
`,.
`..
`•
`..
`"
`•
`"
`..
`"
`,.
`..
`•
`..
`"
`"
`•
`,.
`..
`•
`"
`..
`"
`•
`"
`~»x« ♦ »x«•»x«•»xx«•»x«•»x« ♦ »x« ♦ »!
`
`lit
`
`92
`
`Figure 19a
`
`:···········f ~~ ............. .
`
`..
`..
`•
`
`.
`,.
`..
`"
`
`,.
`
`• .. .. ,.
`• .. .. .. ,.
`• ..
`• ..
`• ~ .............. .
`96
`
`" • ..
`• .,
`
`• • • • ., .. • • ., ..
`
`••••••••••••••
`
`Figure 19b
`
`• . • . • . . • . • . • . • . • . • . • . . •
`
`• . • . • .
`
`" .. A91
`
`" • ..
`" ..
`• .,
`
`• .. ..
`"' ,.
`• ..
`"' ..
`•
`
`. • . • . •
`
`• . • . • . • . • . • . • • • • •
`
`• • • • • • .. .....
`
`.. •
`" .. ..
`"' " • .. ..
`
`" • .. i97
`• • • .. .. .. •
`
`93
`
`Allergan EX1007
`Page 18
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 15 of 21
`
`US 10,478,634 B2
`
`100
`
`100
`
`100
`
`Figure 20a
`
`100
`
`Figure 20b
`
`Allergan EX1007
`Page 19
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 16 of 21
`
`US 10,478,634 B2
`
`103
`
`104
`
`105
`
`107
`
`~114
`
`108
`
`111
`
`112
`
`101
`
`I
`
`102 I
`
`~:-1(:\~-er:-::er: t .;3::;:;~n~-:::-:;{ s.1--------------
`
`110
`113
`, _____________________________________________________ _
`*
`
`j
`
`:
`
`Figure 21
`
`Allergan EX1007
`Page 20
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 17 of 21
`
`US 10,478,634 B2
`
`205
`
`·206
`
`201
`
`~114
`
`202
`
`/202
`
`204
`
`Figure 22a
`
`-.205
`
`206
`
`202
`
`202
`
`203
`
`204
`
`--~
`211
`
`208
`
`Figure 22b
`
`Allergan EX1007
`Page 21
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 18 of 21
`
`US 10,478,634 B2
`
`114
`
`/
`
`301
`
`302
`
`202
`
`102 I
`
`211
`
`.......
`
`..
`
`' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
`
`201
`
`202
`
`301
`
`\L..iJ=::::::r~-~c;_-1 scanntig
`cpw.::s
`
`111
`
`Figure 23a
`
`ii4
`
`I
`
`307
`
`H)2
`
`I
`
`,-. .................. ........,~---~kffl..,.i----~ili"i Scanning ."',
`
`201
`
`306
`
`307
`
`204
`
`Figure 23b
`
`Allergan EX1007
`Page 22
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 19 of 21
`
`US 10,478,634 B2
`
`!
`
`404
`
`405
`
`/VV
`\
`........
`.
`: -._....
`.
`• ♦
`.
`•
`4-o
`..
`..
`--,. !l
`...... •·
`•
`•
`
`•♦
`..
`•
`
`/
`
`~
`
`411
`
`407
`
`nn.n
`/
`. - . - .
`I
`.
`.. - .
`I
`
`408
`
`-
`
`I
`•
`I
`
`Figure 24
`
`Figure 25a
`
`Figure 25b
`
`503
`
`501
`
`501
`
`Allergan EX1007
`Page 23
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 20 of 21
`
`US 10,478,634 B2
`
`Energy
`
`Energy
`
`Energy
`
`Time
`
`Figure 26a
`
`Time
`
`Figure 26b
`
`Time
`
`Figure 26c
`
`Allergan EX1007
`Page 24
`
`

`

`U.S. Patent
`
`Nov. 19, 2019
`
`Sheet 21 of 21
`
`US 10,478,634 B2
`
`~205
`
`206 ...__,.,..
`
`-201
`
`~114
`
`Figure 27
`
`Allergan EX1007
`Page 25
`
`

`

`US 10,478,634 B2
`
`1
`AESTHETIC METHOD OF BIOLOGICAL
`STRUCTURE TREATMENT BY MAGNETIC
`FIELD
`
`PRIORITY CLAIM
`
`5
`
`2
`ing body shape and effects of natural aging. Indeed, patients
`request quick, non-invasive procedures providing satisfac(cid:173)
`tory results with minimal risks.
`The most common methods used for non-invasive aes-
`thetic applications are based on application of mechanical
`waves, e.g. ultrasound or shock wave therapy; or electro(cid:173)
`magnetic waves, e.g. radiofrequency treatment or light treat(cid:173)
`ment, such as intense pulsed light or laser treatment. The
`effect of mechanical waves on tissue is based especially on
`10 cavitation, vibration and/or heat inducing effects. The effect
`of applications using electromagnetic waves is based espe(cid:173)
`cially on heat production in the biological structure. How(cid:173)
`ever the currently used treatment methods are used sepa-
`rately.
`A mechanical treatment using mechanical waves and/or
`pressure were used for treatment of cellulite or adipose cells.
`However, mechanical treatment includes several drawbacks
`such as risk of a panniculitis and/or non-homogenous result.
`A thermal treatment is applied to the patient for enhancing
`20 a visual appearance of the skin by e.g. increasing production
`of collagen and/or elastin, smoothing the skin or reduction
`of cellulite and/or adipose cell. However, thermal treatment
`includes several drawbacks such as risk of overheating a
`patient or even causing a thermal damage to the patient, risk
`25 of a panniculitis and/or non-homogenous result.
`The mechanical and/or the thermal treatment is not able to
`provide enhanced visual appearance of a muscle, e.g. muscle
`shaping, toning and/or volumization effect. Mechanical
`treatment and/or the thermal treatment includes several
`30 drawbacks such as risk of a panniculitis, non-homogenous
`result and others.
`Current magnetic methods are limited in key parameters
`which do not allow satisfactory enhancement of visual
`appearance. As a result, new methods are needed to enhance
`the visual appearance of the patient.
`Existing devices have low efficiency and they waste
`energy, which limits their use. Eddy currents induced within
`the magnetic field generating device create engineering
`challenges. Existing devices contain magnetic field gener(cid:173)
`ating devices which are made of metallic strips, electric
`wires or hollow conductors. Since the therapy requires large
`currents, significant losses are caused by induced eddy
`currents within the magnetic field generating device. Eddy
`currents lead to production of unwanted heat and therefore
`there is need to sufficiently cool the magnetic field gener(cid:173)
`ating device. Also, the energy source must be protected
`during reverse polarity of resonance. This requires using
`protective circuits which consume significant amounts of
`energy. Skin tissue is composed of three basic elements:
`50 epidermis, dermis and hypodermis or so called subcutis. The
`outer and also the thinnest layer of skin is the epidermis. The
`dermis consists of collagen, elastic tissue and reticular
`fibers. The hypodermis is the lowest layer of the skin and
`contains hair follicle roots, lymphatic vessels, collagen
`55 tissue, nerves and also fat forming a subcutaneous white
`adipose tissue (SWAT). The adipose cells create lobules
`which are bounded by connective tissue, fibrous septa (reti(cid:173)
`naculum cutis ).
`Another part of adipose tissue, so called visceral fat, is
`60 located in the peritoneal cavity and forms visceral white
`adipose tissue (VWAT) located between parietal peritoneum
`and visceral peritoneum, closely below muscle fibers adjoin(cid:173)
`ing the hypodermis layer.
`The currently used aesthetic applications don't provide
`any treatment combining the effect of time-varying magnetic
`field treatment and conventional treatment method, e.g.
`treatment by thermal treatment and/or mechanical treatment.
`
`This application is a Continuation-in-Part of U.S. patent
`application Ser. No. 15/954,783, filed Apr. 17, 2018, now
`pending; which is a Continuation-in-Part of U.S. patent
`application Ser. No. 15/862,410, filed Jan. 4, 2018; Ser. No.
`15/677,371 filed Aug. 15, 2017; and Ser. No. 15/601,719,
`filed May 22, 2017; all of which are pending. Application
`Ser. No. 15/862,410 is a Continuation-in-Part of U.S. patent
`application Ser. No. 15/473,390, filed Mar. 29, 2017, now
`pending; and Ser. No. 15/860,443, filed Jan. 2, 2018, now 15
`pending. Application Ser. No. 15/677,371 is a Continuation(cid:173)
`in-Part of U.S. patent application Ser. No. 15/446,951 filed
`Mar. 1, 2017 and now issued as U.S. Pat. No. 9,937,358; and
`Ser. No. 15/404,384 filed Jan. 12, 2017, now pending.
`Application Ser. No. 15/446,951 is a Continuation-in-Part of
`U.S. patent application Ser. No. 15/396,073 filed Dec. 30,
`2016 and now abandoned; which is a Continuation-in-Part
`of U.S. patent application Ser. No. 15/178,455 filed Jun. 9,
`2016, and now pending; which is a Continuation-in-Part of
`U.S. patent application Ser. No. 15/151,012 filed May 10,
`2016, and now pending; which is a Continuation-in-Part of
`U.S. patent application Ser. No. 15/099,274 filed Apr. 14,
`2016, and now abandoned; which is a Continuation-in-Part
`of U.S. patent application Ser. No. 15/073,318 filed Mar. 17,
`2016, and now issued as U.S. Pat. No. 9,919,161; which is
`a Continuation-in-Part of U.S. patent application Ser. No.
`14/951,093 filed Nov. 24, 2015, and now abandoned; which
`is a Continuation-in-Part of U.S. patent application Ser. No.
`14/926,365 filed Oct. 29, 2015 and now abandoned; which
`is a Continuation-in-Part of U.S. patent application Ser. No. 35
`14/789,658 filed Jul. 1, 2015, and issued as U.S. Pat. No.
`9,636,519; and Ser. No. 14/789,156 filed Jul. 1, 2015 and
`now pending.
`Application Ser. No. 15/862,410 claims priority to U.S.
`Provisional Patent Application Nos. 62/440,912 filed Dec. 40
`30, 2016; 62/440,936 filed Dec. 30, 2016; and 62/440,940
`filed Dec. 30, 2016. Application Ser. No. 15/473,390 claims
`priority to U.S. Provisional Patent Application Nos. 62/440,
`905 filed Dec. 30, 2016; 62/440,922 filed Dec. 30, 2016; and
`62/357,679, filed Jul. 1, 2016. Application Ser. No. 15/404, 45
`384 claims priority to U.S. Provisional Patent Application
`No. 62/441,805 filed Jan. 3, 2017.
`All the above-listed applications are incorporated herein
`by reference in their entireties.
`
`FIELD OF THE INVENTION
`
`The present invention generally relates to methods using
`the influence of magnetic and induced electric field on
`biological structure. The magnetic field is time-varying and
`high powered therefore the method is based on a value of
`magnetic flux density sufficient to induce at least muscle
`contraction. The invention proposes further to combine the
`magnetic field with radiofrequency, light, mechanical or
`pressure source in order to provide an apparatus for
`improved treatment.
`
`BACKGROUND OF THE INVENTION
`
`A